I-MAB Stock (NASDAQ: IMAB) stock price, news, charts, stock research, profile.
Open | $1.10 |
Close | $1.08 |
Volume / Avg. | 283.37K / 189.72K |
Day Range | $1.08 - $1.14 |
52 Wk Range | 0.99 - 2.54 |
Market Cap | $87.35M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 2.2% |
Days to Cover | 3.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of I-MAB (NASDAQ:IMAB) through any online brokerage.
Other companies in I-MAB’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
I-MAB has a consensus price target of $12.25.
The stock price for I-MAB (NASDAQ: IMAB) is $1.08 last updated September 20, 2024 at 4:10 PM EDT.
There are no upcoming dividends for I-MAB.
I-MAB’s H1 earnings are confirmed for Wednesday, August 28, 2024.
There is no upcoming split for I-MAB.
I-MAB is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.